非小细胞肺癌术后病理分期升级的影响因素分析  

Analysis of influencing factors of postoperative pathological staging upgrade for non-small cell lung cancer

作　　者：陈勇 唐忠[1] Chen Yong;Tang Zhong(Department of Cardiothoracic Surgery,Neijiang Second People's Hospital,Neijiang,Sichuan 641000,China)

机构地区：[1]内江市第二人民医院心胸外科,四川内江641000

出　　处：《现代临床医学》2024年第1期24-25,32,共3页Journal of Modern Clinical Medicine

摘　　要：目的:探讨非小细胞肺癌术后病理分期升级的影响因素。方法:选取2020年1月至2021年12月在我院心胸外科行肺癌根治术的302例非小细胞肺癌患者为研究对象,根据术后病理分期不同分为IA期组(163例)及>IA期组(139例),统计两组患者的一般资料及疾病相关资料(肿瘤发现方式和肿瘤直径),分析非小细胞肺癌术后病理分期升级的影响因素。结果:logistic回归分析显示,男性、≥60岁、非体检发现及肿瘤直径>2 cm为非小细胞肺癌术后病理分期升级的危险因素(P<0.05)。结论:影响非小细胞肺癌术后病理分期升级的危险因素较多,应加强健康科普教育,提高肺癌早期筛查率,让患者尽早得到诊断和治疗。Objective:To explore the influencing factors of postoperative pathological staging upgrade for non-small cell lung cancer.Methods:A total of 302 non-small cell lung cancer patients who underwent radical lung cancer surgery in Department of Cardiothoracic Surgery in our hospital from January 2020 to December 2021 were selected as the study subjects.They were divided into a stage IA group(163 cases)and a stage IA group(139 cases)based on postoperative pathological staging.The general information and disease-related information including tumor detection method and tumor diameter were collected.The influencing factors of postoperative pathological staging upgrade for non-small cell lung cancer were analyzed.Results:Logistic regression analysis showed that male,≥60 years old,non-discovery during physical examination,and tumor diameter>2 cm were risk factors for postoperative pathological staging upgrade of non-small cell lung cancer(P<0.05).Conclusion:There are many risk factors for the postoperative pathological staging upgrade of non-small cell lung cancer.Health education should be strengthened,and the early screening rate of lung cancer should be improved,so as to enable patients to receive diagnosis and treatment as soon as possible.

关 键 词：非小细胞肺癌 病理分期 影响因素 

分 类 号：R73[医药卫生—肿瘤]